GODWIN C.ZHANG Xue-chun,GODWIN P,et al.Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV- 1 integrase inhibitors [J].J Med Chem,2002,45: 3184-3194.
[2]
RYAN R,DEBORAH J L,EDWARD R J.Inhibition of human immunodeficiency virus type 1 isolates by the integrase in- hibitor L-731,988,a diketo acid[J].Antimicrobial Agents and Chemotherapy,2002,46 (10): 3301-3303.
[3]
MARCHAND C,ZHANG Xue-chun,GODWIN C G,et al,Structural determinants for HIV-1 integrase Inhibition by β- Diketo acids[J].J Biol Chem,2002,277: 12596-12603.
[4]
United Nations Programme on HIV/AIDS (UNAIDS),World Health Organization (WHO) 2004 Hein Marais,Kuren Sta- necki.AIDS epidemic update,December 2004 [EB/OL].(www.unaids.org/wad 2004/report.pdf.html),2004-12-29/ 2005-11-07.
[5]
HAZUDA D,FELOCK P J,HASTINGS J C,et al.Discovery and analysis of inhibitors of the human immunodeficiency in- tegrase[J].Drug Des Discov,1997,15(1): 17-24.
[6]
BUSHMAN F D,CRAIGIE R.Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA[J].Proc Natl Acad Sci USA,1991,88: 1339-1343.
[7]
ERIK D C.Review: New developments in anti-HIV chemotherapy[J].Biochimica et Biophysica Acta (BBA),2002,1587 (2-3): 258-275.
[8]
CRAIGIE R,HIV integrase,a brief of overview from chemistry to therapeutics[J].The Journal of Biological Chemistry, 2001,276 (26): 23213-23216.
[9]
HAZUDA DJ,PETER F,MARC WITMER,et al.inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells[J].Science,2000,287:646-650.
[10]
ESPESETH A S,FELOCK P A,MARC WITMER,et al.HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase[J].Proc Natl Acad Sci USA,2000,97: 11244-11249.
[11]
PLUYMERS W,PAIS G,VAN M B,et al.Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives[J].Antimicrobial Agents and Chemotherapy,2002,46 (10): 3292-3297.
[12]
GOLDGUR Y,CRAIGIE R,GERSON H,et al.Structure of the HIV-1 integrase catalytic domain complexed with an in- hibitor: A platform for antiviral drug design[J].Proc Natl Acad Sci USA,1999,96(23): 13040-13043.
[13]
YOSHIINAGA T,FUJISHITA A S T,FUJIWARA T.S-1360: in Vitro Activity of a New HIV-1 Integrase Inhibitor in Clinical Development[Z].9th conference on Retrovirus and Opportunistic infections,The body health resoupces corportion, 2002.
[14]
HAZUDA D J,STEVE D Y,GUARE J P,et al.Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques[J].Science,2004,305: 528-532.
[15]
GULICK R M.Perspective: Current status of new antiretroviral drugs in development,international AIDS Society-USA, topics in HIV medicine,2002[EB/OL].http://www.iasusa.org/pub/topics/2002/issue4/gulick_arvdrugs.pdf,2002-09- 05/2004-12-08.
[16]
ZHUANG Ling-hang,WAI J S,MARK W E,et al.Design and synthesis of 8-Hydroxy-[ 1,6] naphthyridines as novel in- hibitors of HIV-1 integrase in vitro and in infected cells[J].J Med Chem,2003,46: 453-456.
[17]
HAZUDA D.Review of new antiretroviral agents [EB/OL].42nd International science Conference on Antimicrobial Agents and Chemotherapy (ICAAC),2002,San Diego,CA,(http://www.hivandhepatitis.com/recent/experimental_drugs/ 100202a.html),2002-09-24/2004-10-10.
[18]
HAZUDA D.A novel HIV-1 integrase inhibitor mediates sustained suppression of viral replication and CD4 depletion in a SHIV rhesus macaque model of infection [J].Antivir Ther,2002,7: S3-9.
[19]
CATHRYN A,SHAW-REID,MUNSHI V,et al.Inhibition of HIV-1 Ribonuclease H by a novel diketo acid,4-[5-(Ben- zoylamino)thien-2-yl]-2,4-dioxobutanoic Acid[J].The Journal of Biological Chemistry,2003,278(5): 2777-2780.
[20]
MATSUMOTO H,KIMURA T,YOSHIAKI K,et al.Design,synthesis,and biological evaluation of anti-HIV double drugs: Conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor through spontaneously cleavable linkers [J].Bioorganic & Medicinal Chemistry,2003,9: 1589-1600.
